Janus Henderson Group PLC Rigel Pharmaceuticals Inc Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.1 - $12.2 $72 - $805
66 Added 0.19%
34,336 $40,000
Q2 2022

Aug 15, 2022
SELL
$0.67 - $3.19 $41 - $197
-62 Reduced 0.18%
34,270 $39,000
Q1 2022

May 16, 2022
BUY
$2.22 - $3.45 $15 - $24
7 Added 0.02%
34,332 $102,000
Q4 2021

Feb 14, 2022
BUY
$2.36 - $3.57 $40,745 - $61,636
17,265 Added 101.2%
34,325 $91,000
Q3 2021

Nov 16, 2021
BUY
$3.5 - $4.5 $59,710 - $76,770
17,060 New
17,060 $62,000

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email